Followers

Sunday, October 18, 2020

Serum Institute, Bharat Biotech To Start Intranasal Vaccine Trials: Centre

Serum Institute of India and Bharat Biotech are expected to pursue late stage clinical trials of intranasal COVID-19 vaccines in the coming months once they receive regulatory approval, Health...

from NDTV News - Topstories https://ift.tt/3lXILh9

No comments:

Post a Comment

TCS leads as market cap of 6 six of top 10 most valued firms jumps by Rs 1.18 lakh crore

Last week, six of India's top ten most valuable companies experienced a significant surge in their combined market valuation, totaling R...